Correlation Between IO Biotech and Molecular Pharmacology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IO Biotech and Molecular Pharmacology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IO Biotech and Molecular Pharmacology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IO Biotech and Molecular Pharmacology, you can compare the effects of market volatilities on IO Biotech and Molecular Pharmacology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IO Biotech with a short position of Molecular Pharmacology. Check out your portfolio center. Please also check ongoing floating volatility patterns of IO Biotech and Molecular Pharmacology.

Diversification Opportunities for IO Biotech and Molecular Pharmacology

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between IOBT and Molecular is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding IO Biotech and Molecular Pharmacology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Pharmacology and IO Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IO Biotech are associated (or correlated) with Molecular Pharmacology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Pharmacology has no effect on the direction of IO Biotech i.e., IO Biotech and Molecular Pharmacology go up and down completely randomly.

Pair Corralation between IO Biotech and Molecular Pharmacology

If you would invest  0.01  in Molecular Pharmacology on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Molecular Pharmacology or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

IO Biotech  vs.  Molecular Pharmacology

 Performance 
       Timeline  
IO Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IO Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Molecular Pharmacology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Molecular Pharmacology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

IO Biotech and Molecular Pharmacology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IO Biotech and Molecular Pharmacology

The main advantage of trading using opposite IO Biotech and Molecular Pharmacology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IO Biotech position performs unexpectedly, Molecular Pharmacology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Pharmacology will offset losses from the drop in Molecular Pharmacology's long position.
The idea behind IO Biotech and Molecular Pharmacology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk